Filing Flows › ENvue Medical (FEED) › Q1 2025
ENvue Medical (FEED) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 20, 2025
ENvue Medical (FEED) reported revenue of $1.0M for the first quarter 2025 (Q1 2025), +11% from a year earlier and +131% from the quarter before. Operating margin was -180.7%, net loss $2.5M (243.4% of revenue).
ENvue Medical, Q1 2025: revenue $1.0M (+11% year over year), operating margin -180.7%, net loss $2.5M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0M | +131% | +11% |
| Operating profit | −$1.9M | — | — |
| Net earnings | −$2.5M | — | — |
| Operating cash flow | −$1.3M | — | — |
What changed
Revenue was $1.0M in Q1 2025, up 11% year over year and up 131% from the previous quarter.
Gross margin was 36.0%, down 36.1 points from a year earlier. Operating costs exceeded revenue by $1.9M, an operating margin of -180.7%. Operating expenses grew 80% against revenue growth of 11%. The fastest-growing cost line was Research & development (+338%). The quarter ended with a net loss of $2.5M, wider than the previous quarter's $1.4M loss.
Operating cash flow was −$1.3M. Non-cash charges added back $18K of depreciation and amortization. Working capital and other items added $1.1M. Capital expenditures of $5K exceeded it, leaving free cash flow of −$1.3M.
Questions
What was ENvue Medical's revenue in the first quarter 2025?
ENvue Medical (FEED) reported revenue of $1.0M for the first quarter 2025 (Q1 2025), +11% from a year earlier and +131% from the quarter before.
Was ENvue Medical profitable in the first quarter 2025?
Operating loss was $1.9M (-180.7% of revenue) and net loss $2.5M.
Source: ENvue Medical 10-Q on SEC EDGAR.